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Introduction
The coordinate regulation of differentiation and apoptosis 
is essential for proper development and tissue homeosta-
sis. This synchronous control serves two distinct functions. 
Firstly, in a few cell types, synchronous control of the dif-
ferentiation and apoptotic processes is necessary because 
 functional differentiation requires certain morphologi-
cal events associated with the apoptotic phenotype [1]. 
 Secondly, in many cell types, the signaling pathways con-
trolling differentiation and apoptosis are intertwined to 
assure that either harmful cells or those generated in excess 
are removed in an efficient manner that does not elicit an 
immune response [2, 3]. The formation of skeletal muscle 
utilizes this latter scenario that necessarily results in the dis-
tinct biological endpoints of either differentiation or apop-
tosis [4–7]. While the removal of excess cells is critical during 
development, it is potentially detrimental to regeneration or 
cell therapy. If blocking apoptosis while allowing differentia-
tion is to be considered as a potential approach to increasing 
the efficacy of regeneration or cell therapy, then a thorough 
understanding of how these processes are coordinately reg-
ulated is imperative [8, 9].
To this end, we have previosuly reported that the classi-
cally pro-apoptotic death receptor 5 (DR5)/FADD/caspase 
8 pathway, in cooperation with increased levels of the pro-
apoptotic Bcl2 family member PUMA, plays a role in the 
efficient apoptosis associated with skeletal myoblast dif-
ferentiation [10–12]. Specifically, when myoblasts express-
ing a dominant negative DR5 (dnDR5) are switched from 
growth media (GM) to differentiation media (DM), caspase 
activation, Bid cleavage, and the ensuing apoptosis are 
severely impaired relative to parental myoblasts. However, 
unlike the PUMA pathway, the DR5/FADD/caspase 8 
pathway is also critical to skeletal myoblast differentiation. 
The effect of the DR5/FADD/caspase pathway on differ-
entiation is exerted in GM and results in decreased lev-
els of MyoD mRNA and protein [13]. Thus, we designed 
experiments to delineate the signalling pathway blocked 
by dnDR5, and therefore engaged by DR5, that is respon-
sible for maintaining MyoD mRNA, and thus protein, 
levels. Herein, we present data to indicate that basal sig-
nalling through DR5 and caspase 3 activates p38 kinase 
to regulate serum response factor (SRF)-mediated MyoD 
transcription.
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Basal Signalling Through Death Receptor 5 and Caspase 
3 Activates p38 Kinase to Regulate Serum Response 
Factor (SRF)-Mediated MyoD Transcription
Jason A. Ross, Brianna Barrett, Victoria Bensimon, Girish Shukla and Crystal M. Weyman
We have previously reported that stable expression of a dominant negative Death Receptor 5 (dnDR5) 
in skeletal myoblasts results in decreased basal caspase activity and decreased mRNA and protein 
 expression of the muscle regulatory transcription factor MyoD in growth medium (GM), resulting in 
inhibited  differentation when myoblasts are then cultured in differentiation media (DM). Further, this 
decreased level of MyoD mRNA was not a consequence of altered message stability, but rather  correlated 
with decreased acetylation of histones in the distal regulatory region (DRR) of the MyoD extended 
 promoter known to control MyoD transcription. As serum response factor (SRF) is the transcription factor 
known to be responsible for basal MyoD expression in GM, we compared the level of SRF  binding to the 
 non-canonical serum response element (SRE) within the DRR in parental and dnDR5 expressing myoblasts. 
Herein, we report that stable expression of dnDR5 resulted in decreased levels of serum response  factor 
(SRF) binding to the CArG box in the SRE of the DRR. Total SRF expression levels were not affected, but 
phosphorylation indicative of SRF activation was impaired. This decreased SRF phosphorylation  correlated 
with decreased phosphorylation-induced activation of p38 kinase. Moreover, the aforementioned signaling 
events affected by expression of dnDR5 could be appropriately recapitulated using either a  pharmacological 
inhibitor of caspase 3 or p38 kinase. Thus, our results have established a signaling pathway from DR5 
through caspases to p38 kinase activation, to SRF activation and the basal expression of MyoD.
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Methods
Cells and cell culture
The growth 23A2 myoblasts and 23A2 myoblasts express-
ing dnDR5 have been reported previously [10]. The 
Z-DEVD-fmk caspase inhibitor (20 µM final treatment 
concentration; Calbiochem) and SB 203580 (3 µM treat-
ment concentration; Sigma) were each dissolved in DMSO. 
Appropriate volumes of DMSO or methanol alone were 
added to control cultures and did not exceed 0.15% v/v.
Chromatin immunoprecipitation
ChIP was performed following the protocol provided in 
the EZ-ChIPTM kit (Millipore/Upstate) and as described in 
[13]. Cells were plated on 150 mm plates. The next day, 
cells were fixed in 0.5% formaldehyde for 10 minutes at 
room temperature. Formaldehyde was inactivated by the 
addition of .125 M glycine to the cells for 5 minutes at 
room temperature. Cells were then washed with ice cold 
PBS containing 5 mM Na Butyrate and 0.5 mM PMSF and 
pelleted by centrifugation at 1500 rpm for 5 minutes and 
then resuspended in 5 ml cold Cell Lysis Buffer (CLB: 60 
mM KCl, 15 mM NaCl, 5 mM MgCl, 10 mM Tris pH 7.4, 
300 mM sucrose, 0.1 mM EGTA, 0.1% NP-40, 5 mM Na 
Butyrate, 0.5 mM PMSF). Cells were sonicated once for 
10 sec to ensure lysis of the plasma membrane. Isolated 
nuclei were washed once in 30 ml of CLB and once in 1 ml 
of cold Nuclei Digestion Buffer (Cell Lysis Buffer with-
out NP-40 and PMSF). For MNase digestion, intact nuclei 
were resuspended in 125 µl of Nuclei Lysis Buffer (pre-
warmed to 37°C), digested with MNase (50 units/ml) at 
37°C for 5 minutes, and terminated by 5 mM EDTA. An 
aliquot from each sample was assessed for sufficient chro-
matin fragmentation (500–1000bp) by gel electrophore-
sis. Samples were sonicated twice to ensure lysis of the 
nuclei prior to immunoprecipitation. The remaining steps 
of the immunoprecipitation were performed using the 
EZ ChIP™ Chromatin Immunopreipitation Kit (Upstate) 
per manufacturer’s instructions. Subsequently, anti-SRF 
(Santa Cruz) or appropriate IgG control (Sigma Aldrich) 
were added for immunoprecipitation. For each immuno-
precipitation, 5 µg of the appropriate antibody was incu-
bated with a precleared chromatin aliquot overnight at 
4°C with rotation. The next day, protein A/G sepharose 
beads were added and incubated for 1 hour at 4° with rota-
tion. The immunoprecipitates were pelleted, washed and 
the antibody-protein-DNA complex was eluted from bead 
by incubation in 100 mM NaHCO3 and 1%SDS. Following 
immunoprecipitation and elution, the eluent was treated 
with RNase A followed by reverse crosslinking by incuba-
tion at 65°C overnight. Protein was removed by addition 
of proteinase K and incubation at 45° for 2 hours. DNA 
was purified using mini columns provided by kit manufac-
turer. Purified DNA was amplified by specific primers [13] 
and PCR was performed under the following conditions: 1 
cycle at 95° for 15 min, 40 cycles of 94° 1 min, 58° 1 min, 
72° 1 min; and a final extension step at 72° for 5 minutes 
followed by analysis of melting curve. Data was normal-
ized to the signal detected from the input of each sam-
ple. The fold enrichment of each target site was calculated 
as 2 to the power of the cycle threshold (cT) difference 
between input chromatin and ChIP samples.
Western Analysis
Lysates were prepared and 100 µg were denatured and 
electrophoresed through denaturing polyacrylamide gels 
(10%) followed by electrophoretic transfer as previously 
described. For assessment of phospho-SRF and phospho-
p38 relative to their cognate total protein levels, the same 
lysate was run on separate gels due to the utilization of 
a separate membrane blocking protocol for anti-phos-
pho antibodies relative to the blocking protocol used for 
all other antibodies. For the following antibodies, each 
diluted 1:1000: from Santa Cruz; anti-SRF, from Cell Signal-
ling; anti-p38, and from Abcam; anti-MyoD, membranes 
were blocked for one hour in 1 × TBS/0.1%NP40 with 
10% newborn calf serum and 5% dry milk. For the follow-
ing antibodies, each diluted 1:1000: from Cell Signalling, 
anti-phospho-p38 and anti-phospho-SRF, membranes were 
blocked for one hour in 1 × TBS/0.1%NP40 with 5% BSA. 
Western analysis using anti-actin (Sigma) or anti-hsp70 (BD 
Biosciences) served as loading and transfer controls (each 
diluted 1:30,000). All primary antibodies were incubated 
overnight at 4°C. Appropriate HRP-conjugated secondary 
antibodies, diluted 1:1000, were incubated with the mem-
branes for one hour. After each incubation with antibody 
and prior to the addition of chemiluminescent substrate, 
membranes were washed five times in 1 × TBS (Tris- buff-
ered saline pH 7.4) with 1% Tween 20. Membranes were 
then incubated with (SuperSignal West Pico Chemilumines-
cent Substrate: Thermo Scientific: #34078) for 60  seconds 
and bands were visualized using (Li-Cor Phospho-imager: 
Image Studio Ver. 2.1). Note that multiple Western analy-
sis were run from the same set of  samples to eliminate as 
much variablity as possible.
Quantitative RT-PCR
Myoblasts were plated at equal density and the next day 
cultured as indicated in the figure legend. For quantitative 
RT-PCR, total RNA was prepared using 1 mL of Trizol (Inv-
itrogen) reagent per 100 mm plate for lysis and following 
the manufacturer’s instructions. Five hundred ng of RNA 
was then used for a 20 µL SuperScript III RT (Invitrogen) 
reverse transcription reaction. Quantitative PCR (qPCR) 
was performed for MyoD as described [13] using a Bio-
Rad DNA Engine Opticon 3 Real-Time PCR System using 
SYBR® Green Master PCR Mix according to the manufac-
turer’s instructions (Qiagen).
Results
Effects of dn-DR5 on signaling events regulating 
MyoD expression
SRF is the transcription factor known to drive the expres-
sion of MyoD in GM by binding the CArG box in the serum 
response element (SRE) of the distal regulatory region 
(DRR) of the MyoD gene [14]. To investigate the effect of 
dn-DR5 expression in skeletal myoblasts on the binding of 
SRF to this CArG box, we utilized chromatin immunopre-
cipitation (ChIP) analysis. The binding of SRF to the CArG 
box in the DRR of the MyoD gene in myoblasts express-
ing dn-DR5 was reduced by at least 70% when compared 
to levels of binding in parental control 23A2 myoblasts 
(Figure 1A). Specific phosphorylation of SRF is known to 
enhance the ability of SRF to specifically bind DNA [15]. 
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These decreased levels of SRF bound to the CArG box as a 
consequence of dn-DR5 expression are not a consequence 
of an overall decrease in SRF levels, but rather correlate 
with decreased levels of this specifically phosphorylated 
SRF (Figure 1B and C).
Several reports indicate that p38 kinase plays a pivitol 
role in regulating SRF phosphorylation and transcrip-
tional activity [16–19]. We, therefore, utilized Western 
analysis to investigate the effect of dn-DR5 expression on 
the phosphorylation status of p38 indicative of activation 
[17]. We determined that lysates prepared from myoblasts 
expressing dn-DR5 possessed reduced levels of specifically 
phosphorylated p38, without a corresponding decrease in 
total p38, relative to lysates prepared from parental con-
trol myoblasts (Figure 2A and B).
Effects of caspase 3 inhibition on phosphorylation of 
p38 and subsequent signaling events regulating MyoD 
expression
Phosphorylation and activation of p38 kinase can occur in 
response to a multitude of signaling events, including cas-
pase 3 mediated cleavage of several upstream kinases [17]. 
We have previosuly reported that expression of dn-DR5 
in skeletal myoblasts results in decreased basal caspase 
3 activation [13]. As a second approach to confirm that 
basal signaling from caspase 3 through p38 kinase results 
in phosphorylated SRF and subsequent maintenance of 
MyoD expression, we next treated parental myoblasts 
Figure 1: dnDR5 expression decreases SRF binding to the 
CArG box in the DRR of the MyoD enhancer as well as 
specific phosphorylation of SRF. In (A) chromatin from 
1 × 107 cells was cross-linked and digested with MNase 
to a length between 500–1000 bp. Chromatin Immuno-
precipitation was performed on each cell sample using EZ 
ChIPTM Chromatin Immunoprecipitation Kit (Upstate) 
per manufacturer’s instructions. Chromatin from 2 × 
106 cells was immunoprecipitated as described in Meth-
ods. Quantitative PCR was used to assay for the relative 
levels of SRF binding near MyoD CArG element. Data was 
normalized to the signal detected from the input of each 
sample and presented as a percent of the signal obtained 
from parental 23A2 myoblasts. Error bars represent mean 
+/– SEM of triplicates. In (B) and (C), equal cell numbers 
were plated and the next day lysates were prepared and 
subjected to SDS-PAGE. Western analysis was performed 
using anti-phospho SRF, anti-SRF or anti-β-actin (loading 
and transfer control) and visualized as described in Meth-
ods. Shown are the results of one experiment that are rep-
resentative of three independent experiments for (B) and 
two independent experiments for (C).
Figure 2: dnDR5 expressing myoblasts possess decreased 
levels of specifically phosphorylated p38. For each, 
equal cell numbers were plated and the next day lysates 
were prepared and subjected to SDS-PAGE. Western 
analysis was performed using anti-phospho p38 (A), 
anti-p38 (B), or anti-Hsp70 (loading and transfer con-
trol) and visualized as described in Methods. Shown are 
the results of one experiment that are representative of 
three independent experiments for (A) and two inde-
pendent experiments for (B).
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with the caspase 3 inhibitor DEVD-fmk. Treatment of 
parental myoblasts with DEVD-fmk for either 3 or 6 hours 
resulted in decreased levels of specifically phosphorylated 
p38 kinase (Figure 3A) without a corresponding decrease 
in total p38 (Figure 3B). Moreover, treatment of parental 
myoblasts with DEVD-fmk for either 3 or 6 hours resulted 
in decreased levels of specifically phosphorylated SRF 
(Figure 4A) without a corresponding decrease in total SRF 
(Figure 4B). Finally, treatment of parental myoblasts with 
DEVD-fmk resulted in decreased levels of MyoD protein 
(Figure 5A), a corresponding decrease in MyoD mRNA 
(Figure 5B) and SRF binding to the CArG box in the DRR 
of the MyoD enhancer (Figure 5C). In each aspect meas-
ured, caspase 3 inhibition mimicked the effect of dn-DR5 
expression.
Effects of p38 kinase inhibition on phosphorylation 
of SRF and subsequent signaling events regulating 
MyoD expression
Finally, we treated parental myoblast with the p38 inhibi-
tor SB 203580. Lysates prepared from parental myoblasts 
treated with SB 203580 for either 3 or 6 hours pos-
sessed decreased levels of phosphorylated SRF without a 
decrease in total SRF (Figure 6A and B). This decreased 
level of phosphorylated SRF induced by treatement with 
SB 203580 correlated with a corresponding decrease in 
MyoD protein and mRNA (Figure 7A and B, respectively) 
and decreased levels of SRF binding to the CArG box in the 
DRR of the MyoD enhancer (Figure 7C). In each aspect 
measured, p38 inhibition mimicked the effect of dn-DR5 
expression.
Direct confirmation that a decrease in the binding of 
phosphorylated SRF to the DRR awaits, at a minimum, 
the development of an anti-phospho SRF antibody that 
can be utilized for ChIP analysis. Nonetheless, taken 
together, these data still indicate that a decrease in 
caspase 3 activity, such as that detected upon expres-
sion of dn-DR5 in skeletal myoblasts [13], is sufficient 
to result in decreased phosphorylation and activation 
of p38 kinase, decreased levels of phosphorylated SRF, 
decreased binding of SRF to the CArG box in the DRR 
of the MyoD enhancer and decreased levels of MyoD 
expression (Figure 8/model).
Discussion
A thorough molecular understanding of the coordinate 
regulation of differentiation and apoptosis is pre-req-
uisite to the manipulation of these biologically distinct 
endpoints as a therapeutic approach. For instance, manip-
ulation of the apoptotic pathway, without affecting the dif-
ferentiation pathway, requires identification of molecules 
unique to the apoptotic pathway. To this end, we have pre-
viously reported that the DR5 pathway plays a critical role 
in both the apoptosis and the differentiation of skeletal 
Figure 4: Myoblasts treated with a caspase 3 inhibitor 
possess decreased levels of specifically phosphorylated 
SRF. For each, equal cell numbers were plated and the 
next day treated (or not) with DEVD-fmk as indicated in 
Methods. After the the indicated times, lysates were pre-
pared and subjected to SDS-PAGE. Western analysis was 
performed anti-phospho pSRF (A) or anti-SRF (B). West-
ern analysis using anti-Hsp70 served as the loading and 
transfer controls. Bands were visualized as described in 
Methods. Shown are the results of one experiment that 
are representative of three independent experiments 
for (A) and two independent experiments for (B).
Figure 3: Myoblasts treated with a caspase 3 inhibitor 
possess decreased levels of specifically phosphorylated 
p38. For each, equal cell numbers were plated and the 
next day treated (or not) with DEVD-fmk as indicated in 
Methods. After the the indicated times, lysates were pre-
pared and subjected to SDS-PAGE. Western analysis was 
performed anti-phospho p38 (A) or anti-p38 (B). West-
ern analysis using anti-Hsp70 served as the loading and 
transfer controls. Bands were visualized as described in 
Methods. Shown are the results of one experiment that 
are representative of three independent experiments 
for (A) and two independent experiments for (B).
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myoblasts. In skeletal myoblasts, the DR5 proximal mol-
ecules responsible for executing both the differentiation 
and the apoptotic pathways is caspase 8 signaling through 
caspase 3. The distinction between signaling that allows 
for differentiation and signaling that induces apoptosis 
resides in the level of activation. Specifically, elevated sign-
aling by DR5 in differentiation medium (DM) contributes 
to the apoptosis that occurs in a subset of myoblasts [10], 
while basal signaling from DR5/FADD/caspases in growth 
medium (GM) is necessary to maintain the level of MyoD 
expression and thus allow for the differentiation of the 
majority of myoblasts when cultured in DM [13]. Recently, 
the importance of widespread basal caspase signaling has 
been reported in whole animal studies [20, 21].
A plethora of examples of non-apoptotic roles for apop-
totic molecules have been reported. However, the vast 
majorities of these examples are for Bcl2 family members 
or caspases and rarely have the non-apoptotic signaling 
events downstream of the apoptotic molecules been elu-
cidated [22–24]. The DR5 pathway has been implicated in 
the non-apoptotic role of inducing intestinal cell differ-
entiation, but again the downstream signaling molecules 
were not determined [25]. With respect to myogenesis, a 
role for caspase-3 has been documented at several steps. 
Firstly, caspase-3 activity is required to remove Pax7, 
allowing myoblast stem cells to switch from self-renewal 
to  differentiation competence [26]. Secondly, after myo-
blasts have been switched from GM to DM, caspase-3 
mediated CAD (caspase-activated DNase) activation plays 
a role in the chromatin modification and subsequent 
expression of p21, one of the key molecules required for 
cell cycle exit [27]. Further, in DM, caspase-3 activation 
has been linked to the subsequent activation of p38 [28]. 
Multiple roles for p38 signaling during skeletal myoblast 
differentiation has also been well characterized [29]. 
Figure 5: Myoblasts treated with a caspase 3 inhibitor 
possess decreased levels of MyoD protein, mRNA and 
SRF binding to the CArG box in the DRR of the MyoD 
enhancer. For each, equal cell numbers were plated and 
the next day treated (or not) with DEVD-fmk for the 
indicated times. In (A) Western analysis was performed 
using anti-MyoD or anti-Hsp70 (loading and transfer 
control) and visualized as described in Methods. Shown 
are the results of one experiment that are representative 
of three independent experiments. In (B) quantitative 
RT-PCR was used to assay for the relative levels of MyoD 
mRNA in total RNA samples derived from the indicated 
cell cultures. The Ct values for the MyoD PCR product 
were normalized to the Ct values for a β-actin product, 
run in parallel, as described in Methods. Error bars repre-
sent mean +/– SEM from triplicates. In (C), ChIP analysis 
was perfomed as described in the Figure 1 legend.
Figure 6: Myoblasts treated with a p38 inhibitor possess 
decreased levels of specifically phosphorylated SRF. 
For each, equal cell numbers were plated and the next 
day treated (or not) with SB 203580 for the indicated 
times. In (A) and (B), Western analysis was performed 
using anti-phospho SRF or anti-SRF, respectively with 
anti-actin serving as the loading and transfer control. 
Bands were visualized as described in Methods. Shown 
are the results of one experiment that are representa-
tive of three independent experiments for (A) and two 
independent experiments for (B).
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These elegant studies carefully documented the molecu-
lar effects of caspase-3 and p38 signaling that contrib-
ute to the differentiation process in skeletal myoblasts. 
However, these studies did not address the mechanism(s) 
responsible for caspase-3 activation. Moreover, these 
studies were focused on signaling events that occur once 
myoblasts were cultured in DM.
Our studies were focused on signaling that occurs in 
GM. Herein, we idenitfy the molecules responsive to 
basal DR5 signaling in GM that serve to maintain MyoD 
expression and allow for subsequent differentiation in 
DM. Specifically, we document that basal DR5/caspase 
signaling in GM leads to constitutive phosphorylation and 
activation of the p38 kinase which in turn phosphorylates 
and activates SRF, driving the expression of MyoD. The 
significance of SRF activity in driving MyoD expression in 
skeletal myoblasts in both GM and DM has been well doc-
umented [14, 30]. In DM, SRF activity has been shown to 
be regulated by RhoA [31]. Given that SRF is by definition 
serum responsive via Ras pathway signaling to the ternary 
complex factor (TCF) [32], further exploration of other 
mechansims contributing to the activation of SRF in GM 
has not been exhaustively addressed. Our data support 
a model whereby basal DR5 signaling through caspase-
mediated activation of p38 plays a role in maintaining SRF 
activation and subsequent MyoD expression in GM.
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